Astellas To Set Up Branch Office In Chengdu
This article was originally published in PharmAsia News
Executive Summary
Japanese drug R&D corporation Astellas, ranked 35th on the Fortune 500 list in 2008, will establish a branch office in Chengdu to handle business in southwest and northwest China. The new office will be in charge of marketing promotion in the western region, along with bringing the world's most updated drug information, healthcare developments and market trends to hospitals and doctors. Depending on the market situation, the firm does not rule out the possibility of setting up a pharmaceutical plant or R&D center in the city. Texas Instruments is another Fortune 500 company setting up a base in Chengdu. (Click here for more - Chinese Language)